nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Docetaxel—head and neck cancer	0.0432	0.303	CbGbCtD
Boceprevir—ABCB1—Vinblastine—head and neck cancer	0.0341	0.239	CbGbCtD
Boceprevir—ABCB1—Docetaxel—head and neck cancer	0.0281	0.197	CbGbCtD
Boceprevir—CTSK—skull—head and neck cancer	0.0239	0.0815	CbGeAlD
Boceprevir—CYP3A4—Vinblastine—head and neck cancer	0.0204	0.143	CbGbCtD
Boceprevir—CTSK—cartilage tissue—head and neck cancer	0.0204	0.0695	CbGeAlD
Boceprevir—CTSV—hair follicle—head and neck cancer	0.0171	0.0584	CbGeAlD
Boceprevir—CYP3A4—Docetaxel—head and neck cancer	0.0168	0.118	CbGbCtD
Boceprevir—CTSL—exocrine gland—head and neck cancer	0.0147	0.0501	CbGeAlD
Boceprevir—CTSL—mouth—head and neck cancer	0.011	0.0375	CbGeAlD
Boceprevir—CTSK—hair follicle—head and neck cancer	0.0105	0.036	CbGeAlD
Boceprevir—CTSS—exocrine gland—head and neck cancer	0.00968	0.0331	CbGeAlD
Boceprevir—CTSL—neck—head and neck cancer	0.00937	0.032	CbGeAlD
Boceprevir—CTSK—mouth—head and neck cancer	0.00826	0.0282	CbGeAlD
Boceprevir—CMA1—connective tissue—head and neck cancer	0.00786	0.0268	CbGeAlD
Boceprevir—CTSL—parotid gland—head and neck cancer	0.00763	0.0261	CbGeAlD
Boceprevir—CTSL—saliva-secreting gland—head and neck cancer	0.00731	0.025	CbGeAlD
Boceprevir—CTSS—mouth—head and neck cancer	0.00724	0.0247	CbGeAlD
Boceprevir—CTSV—trachea—head and neck cancer	0.00691	0.0236	CbGeAlD
Boceprevir—CTSL—connective tissue—head and neck cancer	0.00672	0.023	CbGeAlD
Boceprevir—CTSL—epithelium—head and neck cancer	0.00638	0.0218	CbGeAlD
Boceprevir—CTSS—neck—head and neck cancer	0.00619	0.0211	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—head and neck cancer	0.00601	0.0205	CbGeAlD
Boceprevir—CTSK—parotid gland—head and neck cancer	0.00575	0.0197	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—head and neck cancer	0.00574	0.0196	CbGeAlD
Boceprevir—CTSL—trachea—head and neck cancer	0.00564	0.0193	CbGeAlD
Boceprevir—CTSK—saliva-secreting gland—head and neck cancer	0.00551	0.0188	CbGeAlD
Boceprevir—CTSV—thyroid gland—head and neck cancer	0.00546	0.0187	CbGeAlD
Boceprevir—CTSK—connective tissue—head and neck cancer	0.00506	0.0173	CbGeAlD
Boceprevir—CTSS—parotid gland—head and neck cancer	0.00504	0.0172	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—head and neck cancer	0.00491	0.0168	CbGeAlD
Boceprevir—CTSV—head—head and neck cancer	0.00485	0.0166	CbGeAlD
Boceprevir—CTSS—saliva-secreting gland—head and neck cancer	0.00483	0.0165	CbGeAlD
Boceprevir—CTSL—thyroid gland—head and neck cancer	0.00446	0.0152	CbGeAlD
Boceprevir—CTSS—connective tissue—head and neck cancer	0.00444	0.0152	CbGeAlD
Boceprevir—CTSK—trachea—head and neck cancer	0.00425	0.0145	CbGeAlD
Boceprevir—CTSL—head—head and neck cancer	0.00396	0.0135	CbGeAlD
Boceprevir—CTSS—trachea—head and neck cancer	0.00372	0.0127	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—head and neck cancer	0.0037	0.0126	CbGeAlD
Boceprevir—CTSK—thyroid gland—head and neck cancer	0.00336	0.0115	CbGeAlD
Boceprevir—CTSS—lymphoid tissue—head and neck cancer	0.00324	0.0111	CbGeAlD
Boceprevir—CMA1—lymph node—head and neck cancer	0.00324	0.0111	CbGeAlD
Boceprevir—CTSK—head—head and neck cancer	0.00298	0.0102	CbGeAlD
Boceprevir—CTSS—thyroid gland—head and neck cancer	0.00295	0.0101	CbGeAlD
Boceprevir—CTSL—lymph node—head and neck cancer	0.00277	0.00947	CbGeAlD
Boceprevir—CTSS—head—head and neck cancer	0.00261	0.00893	CbGeAlD
Boceprevir—Haemorrhoids—Docetaxel—head and neck cancer	0.00237	0.00775	CcSEcCtD
Boceprevir—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00229	0.00749	CcSEcCtD
Boceprevir—Polyp—Docetaxel—head and neck cancer	0.00229	0.00749	CcSEcCtD
Boceprevir—Parosmia—Docetaxel—head and neck cancer	0.00215	0.00703	CcSEcCtD
Boceprevir—Cellulitis—Fluorouracil—head and neck cancer	0.00213	0.00694	CcSEcCtD
Boceprevir—Lacrimation increased—Fluorouracil—head and neck cancer	0.0021	0.00685	CcSEcCtD
Boceprevir—Herpes simplex—Fluorouracil—head and neck cancer	0.0021	0.00685	CcSEcCtD
Boceprevir—CTSK—lymph node—head and neck cancer	0.00209	0.00713	CbGeAlD
Boceprevir—Cyst—Docetaxel—head and neck cancer	0.00209	0.00682	CcSEcCtD
Boceprevir—Neuralgia—Docetaxel—head and neck cancer	0.00201	0.00656	CcSEcCtD
Boceprevir—CTSS—lymph node—head and neck cancer	0.00183	0.00625	CbGeAlD
Boceprevir—Rash erythematous—Docetaxel—head and neck cancer	0.00182	0.00595	CcSEcCtD
Boceprevir—Photophobia—Fluorouracil—head and neck cancer	0.00182	0.00593	CcSEcCtD
Boceprevir—Otitis media—Docetaxel—head and neck cancer	0.00179	0.00585	CcSEcCtD
Boceprevir—Breast disorder—Hydroxyurea—head and neck cancer	0.00176	0.00575	CcSEcCtD
Boceprevir—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00176	0.00574	CcSEcCtD
Boceprevir—Pancytopenia—Vinblastine—head and neck cancer	0.00176	0.00573	CcSEcCtD
Boceprevir—Sepsis—Fluorouracil—head and neck cancer	0.00168	0.00548	CcSEcCtD
Boceprevir—Pancreatitis—Hydroxyurea—head and neck cancer	0.00165	0.0054	CcSEcCtD
Boceprevir—Depression—Vinblastine—head and neck cancer	0.00164	0.00537	CcSEcCtD
Boceprevir—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00162	0.00528	CcSEcCtD
Boceprevir—Pancytopenia—Hydroxyurea—head and neck cancer	0.0016	0.00523	CcSEcCtD
Boceprevir—Amenorrhoea—Docetaxel—head and neck cancer	0.00159	0.00519	CcSEcCtD
Boceprevir—Chest discomfort—Docetaxel—head and neck cancer	0.00158	0.00515	CcSEcCtD
Boceprevir—Dysuria—Hydroxyurea—head and neck cancer	0.00158	0.00515	CcSEcCtD
Boceprevir—Neutropenia—Hydroxyurea—head and neck cancer	0.00158	0.00515	CcSEcCtD
Boceprevir—Agranulocytosis—Vinblastine—head and neck cancer	0.00154	0.00502	CcSEcCtD
Boceprevir—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00154	0.00501	CcSEcCtD
Boceprevir—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00154	0.00501	CcSEcCtD
Boceprevir—Lacrimation increased—Docetaxel—head and neck cancer	0.00151	0.00495	CcSEcCtD
Boceprevir—Infestation—Hydroxyurea—head and neck cancer	0.0015	0.00491	CcSEcCtD
Boceprevir—Infestation NOS—Hydroxyurea—head and neck cancer	0.0015	0.00491	CcSEcCtD
Boceprevir—Amnesia—Fluorouracil—head and neck cancer	0.00149	0.00488	CcSEcCtD
Boceprevir—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00147	0.00481	CcSEcCtD
Boceprevir—Hypoaesthesia—Vinblastine—head and neck cancer	0.00147	0.00481	CcSEcCtD
Boceprevir—Pharyngitis—Vinblastine—head and neck cancer	0.00147	0.00479	CcSEcCtD
Boceprevir—Hearing impaired—Docetaxel—head and neck cancer	0.00147	0.00479	CcSEcCtD
Boceprevir—Stomatitis—Hydroxyurea—head and neck cancer	0.00147	0.00478	CcSEcCtD
Boceprevir—Bone pain—Docetaxel—head and neck cancer	0.00146	0.00476	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—STAT6—head and neck cancer	0.00145	0.00562	CbGpPWpGaD
Boceprevir—Lethargy—Fluorouracil—head and neck cancer	0.00143	0.00468	CcSEcCtD
Boceprevir—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00142	0.00464	CcSEcCtD
Boceprevir—Respiratory failure—Docetaxel—head and neck cancer	0.00142	0.00464	CcSEcCtD
Boceprevir—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.0014	0.00541	CbGpPWpGaD
Boceprevir—Pulmonary embolism—Docetaxel—head and neck cancer	0.0014	0.00456	CcSEcCtD
Boceprevir—Injection site reaction—Docetaxel—head and neck cancer	0.00139	0.00453	CcSEcCtD
Boceprevir—Influenza like illness—Docetaxel—head and neck cancer	0.00136	0.00443	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—CASP8—head and neck cancer	0.00135	0.00522	CbGpPWpGaD
Boceprevir—Colitis—Docetaxel—head and neck cancer	0.00134	0.00438	CcSEcCtD
Boceprevir—Irritability—Fluorouracil—head and neck cancer	0.00134	0.00438	CcSEcCtD
Boceprevir—Candida infection—Docetaxel—head and neck cancer	0.00133	0.00435	CcSEcCtD
Boceprevir—Alopecia—Vinblastine—head and neck cancer	0.00131	0.00427	CcSEcCtD
Boceprevir—Dry skin—Fluorouracil—head and neck cancer	0.00129	0.0042	CcSEcCtD
Boceprevir—Neoplasm—Docetaxel—head and neck cancer	0.00126	0.00412	CcSEcCtD
Boceprevir—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00126	0.0041	CcSEcCtD
Boceprevir—CTSV—Endochondral Ossification—AKT1—head and neck cancer	0.00125	0.00485	CbGpPWpGaD
Boceprevir—Muscular weakness—Fluorouracil—head and neck cancer	0.00124	0.00404	CcSEcCtD
Boceprevir—Angiopathy—Hydroxyurea—head and neck cancer	0.00122	0.004	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—GRP—head and neck cancer	0.00121	0.0047	CbGpPWpGaD
Boceprevir—Dysphagia—Fluorouracil—head and neck cancer	0.00121	0.00396	CcSEcCtD
Boceprevir—Sepsis—Docetaxel—head and neck cancer	0.00121	0.00396	CcSEcCtD
Boceprevir—Chills—Hydroxyurea—head and neck cancer	0.00121	0.00395	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—STAT6—head and neck cancer	0.0012	0.00465	CbGpPWpGaD
Boceprevir—Eosinophilia—Fluorouracil—head and neck cancer	0.0012	0.00392	CcSEcCtD
Boceprevir—Ill-defined disorder—Vinblastine—head and neck cancer	0.0012	0.0039	CcSEcCtD
Boceprevir—Alopecia—Hydroxyurea—head and neck cancer	0.00119	0.00389	CcSEcCtD
Boceprevir—Anaemia—Vinblastine—head and neck cancer	0.00119	0.00389	CcSEcCtD
Boceprevir—Erythema—Hydroxyurea—head and neck cancer	0.00117	0.00384	CcSEcCtD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—head and neck cancer	0.00117	0.00454	CbGpPWpGaD
Boceprevir—Malaise—Vinblastine—head and neck cancer	0.00116	0.00379	CcSEcCtD
Boceprevir—Vertigo—Vinblastine—head and neck cancer	0.00116	0.00378	CcSEcCtD
Boceprevir—Leukopenia—Vinblastine—head and neck cancer	0.00115	0.00376	CcSEcCtD
Boceprevir—Pancytopenia—Fluorouracil—head and neck cancer	0.00115	0.00376	CcSEcCtD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—head and neck cancer	0.00114	0.00442	CbGpPWpGaD
Boceprevir—Deafness—Docetaxel—head and neck cancer	0.00113	0.0037	CcSEcCtD
Boceprevir—Hypertension—Vinblastine—head and neck cancer	0.00111	0.00363	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—CASP8—head and neck cancer	0.00111	0.0043	CbGpPWpGaD
Boceprevir—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00111	0.00362	CcSEcCtD
Boceprevir—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00109	0.00356	CcSEcCtD
Boceprevir—Pneumonia—Fluorouracil—head and neck cancer	0.00109	0.00355	CcSEcCtD
Boceprevir—Anaemia—Hydroxyurea—head and neck cancer	0.00109	0.00354	CcSEcCtD
Boceprevir—Discomfort—Vinblastine—head and neck cancer	0.00108	0.00354	CcSEcCtD
Boceprevir—Infestation NOS—Fluorouracil—head and neck cancer	0.00108	0.00353	CcSEcCtD
Boceprevir—Infestation—Fluorouracil—head and neck cancer	0.00108	0.00353	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—PTEN—head and neck cancer	0.00108	0.00416	CbGpPWpGaD
Boceprevir—Atrial fibrillation—Docetaxel—head and neck cancer	0.00107	0.00349	CcSEcCtD
Boceprevir—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00106	0.00346	CcSEcCtD
Boceprevir—Malaise—Hydroxyurea—head and neck cancer	0.00106	0.00346	CcSEcCtD
Boceprevir—Stomatitis—Fluorouracil—head and neck cancer	0.00105	0.00344	CcSEcCtD
Boceprevir—Conjunctivitis—Fluorouracil—head and neck cancer	0.00105	0.00343	CcSEcCtD
Boceprevir—Urinary tract infection—Fluorouracil—head and neck cancer	0.00105	0.00343	CcSEcCtD
Boceprevir—Leukopenia—Hydroxyurea—head and neck cancer	0.00105	0.00343	CcSEcCtD
Boceprevir—Lethargy—Docetaxel—head and neck cancer	0.00103	0.00338	CcSEcCtD
Boceprevir—Thrombocytopenia—Vinblastine—head and neck cancer	0.00103	0.00336	CcSEcCtD
Boceprevir—Epistaxis—Fluorouracil—head and neck cancer	0.00102	0.00333	CcSEcCtD
Boceprevir—Sinusitis—Fluorouracil—head and neck cancer	0.00102	0.00331	CcSEcCtD
Boceprevir—Pain in extremity—Docetaxel—head and neck cancer	0.00101	0.00331	CcSEcCtD
Boceprevir—Agranulocytosis—Fluorouracil—head and neck cancer	0.00101	0.0033	CcSEcCtD
Boceprevir—Migraine—Docetaxel—head and neck cancer	0.000997	0.00326	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000993	0.00324	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—STAT6—head and neck cancer	0.00099	0.00383	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—MAPK3—head and neck cancer	0.000988	0.00383	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—MAPK3—head and neck cancer	0.000988	0.00383	CbGpPWpGaD
Boceprevir—Discomfort—Hydroxyurea—head and neck cancer	0.000988	0.00323	CcSEcCtD
Boceprevir—Rhinitis—Fluorouracil—head and neck cancer	0.000974	0.00318	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—CDH1—head and neck cancer	0.000973	0.00377	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CDH1—head and neck cancer	0.000973	0.00377	CbGpPWpGaD
Boceprevir—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000966	0.00316	CcSEcCtD
Boceprevir—Pharyngitis—Fluorouracil—head and neck cancer	0.000964	0.00315	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—STAT3—head and neck cancer	0.000962	0.00372	CbGpPWpGaD
Boceprevir—Infection—Hydroxyurea—head and neck cancer	0.000952	0.00311	CcSEcCtD
Boceprevir—Paraesthesia—Vinblastine—head and neck cancer	0.000944	0.00308	CcSEcCtD
Boceprevir—Dehydration—Docetaxel—head and neck cancer	0.000942	0.00308	CcSEcCtD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000942	0.00365	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—MAPK1—head and neck cancer	0.00094	0.00364	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—MAPK1—head and neck cancer	0.00094	0.00364	CbGpPWpGaD
Boceprevir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00094	0.00307	CcSEcCtD
Boceprevir—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000939	0.00306	CcSEcCtD
Boceprevir—Skin disorder—Hydroxyurea—head and neck cancer	0.000931	0.00304	CcSEcCtD
Boceprevir—Dry skin—Docetaxel—head and neck cancer	0.000929	0.00303	CcSEcCtD
Boceprevir—Abdominal pain upper—Docetaxel—head and neck cancer	0.000926	0.00302	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—MAPK3—head and neck cancer	0.000919	0.00356	CbGpPWpGaD
Boceprevir—Breast disorder—Docetaxel—head and neck cancer	0.000916	0.00299	CcSEcCtD
Boceprevir—Decreased appetite—Vinblastine—head and neck cancer	0.000914	0.00298	CcSEcCtD
Boceprevir—Nasopharyngitis—Docetaxel—head and neck cancer	0.000906	0.00296	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—CDH1—head and neck cancer	0.000905	0.0035	CbGpPWpGaD
Boceprevir—Pain—Vinblastine—head and neck cancer	0.000899	0.00294	CcSEcCtD
Boceprevir—Constipation—Vinblastine—head and neck cancer	0.000899	0.00294	CcSEcCtD
Boceprevir—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000881	0.00341	CbGpPWpGaD
Boceprevir—Dysphagia—Docetaxel—head and neck cancer	0.000876	0.00286	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—MAPK1—head and neck cancer	0.000874	0.00338	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—head and neck cancer	0.000874	0.00338	CbGpPWpGaD
Boceprevir—Arrhythmia—Fluorouracil—head and neck cancer	0.000868	0.00283	CcSEcCtD
Boceprevir—Feeling abnormal—Vinblastine—head and neck cancer	0.000866	0.00283	CcSEcCtD
Boceprevir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00086	0.00281	CcSEcCtD
Boceprevir—Alopecia—Fluorouracil—head and neck cancer	0.000858	0.0028	CcSEcCtD
Boceprevir—Dyspnoea—Hydroxyurea—head and neck cancer	0.000855	0.00279	CcSEcCtD
Boceprevir—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000846	0.00327	CbGpPWpGaD
Boceprevir—Erythema—Fluorouracil—head and neck cancer	0.000846	0.00276	CcSEcCtD
Boceprevir—CTSV—Immune System—STAT6—head and neck cancer	0.000845	0.00327	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT6—head and neck cancer	0.000845	0.00327	CbGpPWpGaD
Boceprevir—Dyspepsia—Hydroxyurea—head and neck cancer	0.000844	0.00276	CcSEcCtD
Boceprevir—Decreased appetite—Hydroxyurea—head and neck cancer	0.000833	0.00272	CcSEcCtD
Boceprevir—Pancytopenia—Docetaxel—head and neck cancer	0.000832	0.00272	CcSEcCtD
Boceprevir—Abdominal pain—Vinblastine—head and neck cancer	0.000831	0.00271	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000828	0.0027	CcSEcCtD
Boceprevir—Fatigue—Hydroxyurea—head and neck cancer	0.000827	0.0027	CcSEcCtD
Boceprevir—Pain—Hydroxyurea—head and neck cancer	0.00082	0.00268	CcSEcCtD
Boceprevir—Constipation—Hydroxyurea—head and neck cancer	0.00082	0.00268	CcSEcCtD
Boceprevir—Neutropenia—Docetaxel—head and neck cancer	0.000819	0.00267	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—MAPK3—head and neck cancer	0.000819	0.00317	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—CDH1—head and neck cancer	0.000806	0.00312	CbGpPWpGaD
Boceprevir—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000802	0.0031	CbGpPWpGaD
Boceprevir—Vision blurred—Fluorouracil—head and neck cancer	0.000797	0.0026	CcSEcCtD
Boceprevir—Weight decreased—Docetaxel—head and neck cancer	0.000792	0.00259	CcSEcCtD
Boceprevir—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00079	0.00258	CcSEcCtD
Boceprevir—Pneumonia—Docetaxel—head and neck cancer	0.000785	0.00256	CcSEcCtD
Boceprevir—Anaemia—Fluorouracil—head and neck cancer	0.000781	0.00255	CcSEcCtD
Boceprevir—Infestation NOS—Docetaxel—head and neck cancer	0.000781	0.00255	CcSEcCtD
Boceprevir—Infestation—Docetaxel—head and neck cancer	0.000781	0.00255	CcSEcCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—MAPK1—head and neck cancer	0.000779	0.00302	CbGpPWpGaD
Boceprevir—Hypersensitivity—Vinblastine—head and neck cancer	0.000774	0.00253	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000774	0.00253	CcSEcCtD
Boceprevir—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000765	0.0025	CcSEcCtD
Boceprevir—Stomatitis—Docetaxel—head and neck cancer	0.000761	0.00249	CcSEcCtD
Boceprevir—Conjunctivitis—Docetaxel—head and neck cancer	0.000759	0.00248	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—PIK3CA—head and neck cancer	0.000759	0.00294	CbGpPWpGaD
Boceprevir—Body temperature increased—Hydroxyurea—head and neck cancer	0.000758	0.00247	CcSEcCtD
Boceprevir—Leukopenia—Fluorouracil—head and neck cancer	0.000757	0.00247	CcSEcCtD
Boceprevir—Asthenia—Vinblastine—head and neck cancer	0.000754	0.00246	CcSEcCtD
Boceprevir—ABCB1—epithelium—head and neck cancer	0.000743	0.00254	CbGeAlD
Boceprevir—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000739	0.00241	CcSEcCtD
Boceprevir—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000737	0.00285	CbGpPWpGaD
Boceprevir—Epistaxis—Docetaxel—head and neck cancer	0.000737	0.0024	CcSEcCtD
Boceprevir—Agranulocytosis—Docetaxel—head and neck cancer	0.000729	0.00238	CcSEcCtD
Boceprevir—Myalgia—Fluorouracil—head and neck cancer	0.00072	0.00235	CcSEcCtD
Boceprevir—Chest pain—Fluorouracil—head and neck cancer	0.00072	0.00235	CcSEcCtD
Boceprevir—Diarrhoea—Vinblastine—head and neck cancer	0.000719	0.00235	CcSEcCtD
Boceprevir—Discomfort—Fluorouracil—head and neck cancer	0.000711	0.00232	CcSEcCtD
Boceprevir—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000709	0.00274	CbGpPWpGaD
Boceprevir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000706	0.00231	CcSEcCtD
Boceprevir—Rhinitis—Docetaxel—head and neck cancer	0.000703	0.00229	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—HRAS—head and neck cancer	0.000702	0.00272	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT6—head and neck cancer	0.0007	0.00271	CbGpPWpGaD
Boceprevir—Hypoaesthesia—Docetaxel—head and neck cancer	0.000698	0.00228	CcSEcCtD
Boceprevir—Confusional state—Fluorouracil—head and neck cancer	0.000696	0.00227	CcSEcCtD
Boceprevir—Pharyngitis—Docetaxel—head and neck cancer	0.000696	0.00227	CcSEcCtD
Boceprevir—Dizziness—Vinblastine—head and neck cancer	0.000695	0.00227	CcSEcCtD
Boceprevir—Urinary tract disorder—Docetaxel—head and neck cancer	0.000692	0.00226	CcSEcCtD
Boceprevir—Oedema peripheral—Docetaxel—head and neck cancer	0.000691	0.00225	CcSEcCtD
Boceprevir—Connective tissue disorder—Docetaxel—head and neck cancer	0.000689	0.00225	CcSEcCtD
Boceprevir—Asthenia—Hydroxyurea—head and neck cancer	0.000688	0.00225	CcSEcCtD
Boceprevir—Urethral disorder—Docetaxel—head and neck cancer	0.000687	0.00224	CcSEcCtD
Boceprevir—Infection—Fluorouracil—head and neck cancer	0.000686	0.00224	CcSEcCtD
Boceprevir—Nervous system disorder—Fluorouracil—head and neck cancer	0.000677	0.00221	CcSEcCtD
Boceprevir—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000676	0.00221	CcSEcCtD
Boceprevir—Visual impairment—Docetaxel—head and neck cancer	0.000676	0.00221	CcSEcCtD
Boceprevir—CTSS—Toll-Like Receptors Cascades—MAPK3—head and neck cancer	0.000674	0.00261	CbGpPWpGaD
Boceprevir—Tachycardia—Fluorouracil—head and neck cancer	0.000673	0.0022	CcSEcCtD
Boceprevir—Vomiting—Vinblastine—head and neck cancer	0.000668	0.00218	CcSEcCtD
Boceprevir—CTSS—Extracellular matrix organization—CDH1—head and neck cancer	0.000664	0.00257	CbGpPWpGaD
Boceprevir—Erythema multiforme—Docetaxel—head and neck cancer	0.000663	0.00216	CcSEcCtD
Boceprevir—Headache—Vinblastine—head and neck cancer	0.000659	0.00215	CcSEcCtD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000658	0.00255	CbGpPWpGaD
Boceprevir—ABCB1—trachea—head and neck cancer	0.000657	0.00224	CbGeAlD
Boceprevir—Diarrhoea—Hydroxyurea—head and neck cancer	0.000656	0.00214	CcSEcCtD
Boceprevir—Eye disorder—Docetaxel—head and neck cancer	0.000655	0.00214	CcSEcCtD
Boceprevir—Flushing—Docetaxel—head and neck cancer	0.000651	0.00212	CcSEcCtD
Boceprevir—Cardiac disorder—Docetaxel—head and neck cancer	0.000651	0.00212	CcSEcCtD
Boceprevir—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00065	0.00252	CbGpPWpGaD
Boceprevir—Hypotension—Fluorouracil—head and neck cancer	0.000645	0.00211	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—BCL2L1—head and neck cancer	0.000645	0.0025	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—BCL2L1—head and neck cancer	0.000645	0.0025	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—MAPK1—head and neck cancer	0.000642	0.00248	CbGpPWpGaD
Boceprevir—Angiopathy—Docetaxel—head and neck cancer	0.000636	0.00208	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—KISS1—head and neck cancer	0.000635	0.00246	CbGpPWpGaD
Boceprevir—Dizziness—Hydroxyurea—head and neck cancer	0.000634	0.00207	CcSEcCtD
Boceprevir—Immune system disorder—Docetaxel—head and neck cancer	0.000633	0.00207	CcSEcCtD
Boceprevir—Mediastinal disorder—Docetaxel—head and neck cancer	0.000632	0.00206	CcSEcCtD
Boceprevir—Chills—Docetaxel—head and neck cancer	0.000629	0.00205	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000629	0.00205	CcSEcCtD
Boceprevir—Arrhythmia—Docetaxel—head and neck cancer	0.000626	0.00204	CcSEcCtD
Boceprevir—Nausea—Vinblastine—head and neck cancer	0.000624	0.00204	CcSEcCtD
Boceprevir—Insomnia—Fluorouracil—head and neck cancer	0.000624	0.00204	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—AKT1—head and neck cancer	0.00062	0.0024	CbGpPWpGaD
Boceprevir—Paraesthesia—Fluorouracil—head and neck cancer	0.00062	0.00202	CcSEcCtD
Boceprevir—Alopecia—Docetaxel—head and neck cancer	0.000619	0.00202	CcSEcCtD
Boceprevir—Dyspnoea—Fluorouracil—head and neck cancer	0.000615	0.00201	CcSEcCtD
Boceprevir—Mental disorder—Docetaxel—head and neck cancer	0.000614	0.00201	CcSEcCtD
Boceprevir—Erythema—Docetaxel—head and neck cancer	0.00061	0.00199	CcSEcCtD
Boceprevir—Malnutrition—Docetaxel—head and neck cancer	0.00061	0.00199	CcSEcCtD
Boceprevir—Vomiting—Hydroxyurea—head and neck cancer	0.00061	0.00199	CcSEcCtD
Boceprevir—Dyspepsia—Fluorouracil—head and neck cancer	0.000607	0.00198	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000606	0.00234	CbGpPWpGaD
Boceprevir—Rash—Hydroxyurea—head and neck cancer	0.000604	0.00197	CcSEcCtD
Boceprevir—Dermatitis—Hydroxyurea—head and neck cancer	0.000604	0.00197	CcSEcCtD
Boceprevir—Headache—Hydroxyurea—head and neck cancer	0.000601	0.00196	CcSEcCtD
Boceprevir—Decreased appetite—Fluorouracil—head and neck cancer	0.0006	0.00196	CcSEcCtD
Boceprevir—Dysgeusia—Docetaxel—head and neck cancer	0.000598	0.00195	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000597	0.00231	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000596	0.00195	CcSEcCtD
Boceprevir—Back pain—Docetaxel—head and neck cancer	0.00059	0.00193	CcSEcCtD
Boceprevir—Pain—Fluorouracil—head and neck cancer	0.00059	0.00193	CcSEcCtD
Boceprevir—Muscle spasms—Docetaxel—head and neck cancer	0.000587	0.00192	CcSEcCtD
Boceprevir—CTSS—Immune System—STAT6—head and neck cancer	0.000576	0.00223	CbGpPWpGaD
Boceprevir—ABCB1—lymphoid tissue—head and neck cancer	0.000572	0.00195	CbGeAlD
Boceprevir—Nausea—Hydroxyurea—head and neck cancer	0.000569	0.00186	CcSEcCtD
Boceprevir—Feeling abnormal—Fluorouracil—head and neck cancer	0.000569	0.00186	CcSEcCtD
Boceprevir—Anaemia—Docetaxel—head and neck cancer	0.000564	0.00184	CcSEcCtD
Boceprevir—Urticaria—Fluorouracil—head and neck cancer	0.000548	0.00179	CcSEcCtD
Boceprevir—Syncope—Docetaxel—head and neck cancer	0.000547	0.00179	CcSEcCtD
Boceprevir—Leukopenia—Docetaxel—head and neck cancer	0.000546	0.00178	CcSEcCtD
Boceprevir—Body temperature increased—Fluorouracil—head and neck cancer	0.000545	0.00178	CcSEcCtD
Boceprevir—Palpitations—Docetaxel—head and neck cancer	0.000539	0.00176	CcSEcCtD
Boceprevir—Loss of consciousness—Docetaxel—head and neck cancer	0.000536	0.00175	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—BCL2L1—head and neck cancer	0.000534	0.00207	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000534	0.00207	CbGpPWpGaD
Boceprevir—Cough—Docetaxel—head and neck cancer	0.000533	0.00174	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CASP8—head and neck cancer	0.000527	0.00204	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CASP8—head and neck cancer	0.000527	0.00204	CbGpPWpGaD
Boceprevir—Hypertension—Docetaxel—head and neck cancer	0.000527	0.00172	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GRP—head and neck cancer	0.000523	0.00202	CbGpPWpGaD
Boceprevir—ABCB1—thyroid gland—head and neck cancer	0.00052	0.00178	CbGeAlD
Boceprevir—Myalgia—Docetaxel—head and neck cancer	0.00052	0.0017	CcSEcCtD
Boceprevir—Arthralgia—Docetaxel—head and neck cancer	0.00052	0.0017	CcSEcCtD
Boceprevir—Chest pain—Docetaxel—head and neck cancer	0.00052	0.0017	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000516	0.00168	CcSEcCtD
Boceprevir—Hypersensitivity—Fluorouracil—head and neck cancer	0.000508	0.00166	CcSEcCtD
Boceprevir—Dry mouth—Docetaxel—head and neck cancer	0.000508	0.00166	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—STAT6—head and neck cancer	0.000508	0.00197	CbGpPWpGaD
Boceprevir—Confusional state—Docetaxel—head and neck cancer	0.000502	0.00164	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—CDH1—head and neck cancer	0.0005	0.00194	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CDH1—head and neck cancer	0.0005	0.00194	CbGpPWpGaD
Boceprevir—Infection—Docetaxel—head and neck cancer	0.000495	0.00162	CcSEcCtD
Boceprevir—Shock—Docetaxel—head and neck cancer	0.00049	0.0016	CcSEcCtD
Boceprevir—Nervous system disorder—Docetaxel—head and neck cancer	0.000488	0.00159	CcSEcCtD
Boceprevir—Pruritus—Fluorouracil—head and neck cancer	0.000488	0.00159	CcSEcCtD
Boceprevir—Thrombocytopenia—Docetaxel—head and neck cancer	0.000488	0.00159	CcSEcCtD
Boceprevir—Tachycardia—Docetaxel—head and neck cancer	0.000486	0.00159	CcSEcCtD
Boceprevir—Skin disorder—Docetaxel—head and neck cancer	0.000484	0.00158	CcSEcCtD
Boceprevir—Diarrhoea—Fluorouracil—head and neck cancer	0.000472	0.00154	CcSEcCtD
Boceprevir—Hypotension—Docetaxel—head and neck cancer	0.000465	0.00152	CcSEcCtD
Boceprevir—ABCB1—head—head and neck cancer	0.000461	0.00158	CbGeAlD
Boceprevir—Dizziness—Fluorouracil—head and neck cancer	0.000456	0.00149	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000454	0.00148	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—BCL2—head and neck cancer	0.000452	0.00175	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—BCL2—head and neck cancer	0.000452	0.00175	CbGpPWpGaD
Boceprevir—Insomnia—Docetaxel—head and neck cancer	0.00045	0.00147	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—YAP1—head and neck cancer	0.000449	0.00174	CbGpPWpGaD
Boceprevir—Paraesthesia—Docetaxel—head and neck cancer	0.000447	0.00146	CcSEcCtD
Boceprevir—Dyspnoea—Docetaxel—head and neck cancer	0.000444	0.00145	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—BCL2L1—head and neck cancer	0.00044	0.0017	CbGpPWpGaD
Boceprevir—Vomiting—Fluorouracil—head and neck cancer	0.000439	0.00143	CcSEcCtD
Boceprevir—Dyspepsia—Docetaxel—head and neck cancer	0.000438	0.00143	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CASP8—head and neck cancer	0.000437	0.00169	CbGpPWpGaD
Boceprevir—Rash—Fluorouracil—head and neck cancer	0.000435	0.00142	CcSEcCtD
Boceprevir—Dermatitis—Fluorouracil—head and neck cancer	0.000435	0.00142	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—head and neck cancer	0.000433	0.00141	CcSEcCtD
Boceprevir—Headache—Fluorouracil—head and neck cancer	0.000432	0.00141	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00043	0.0014	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—head and neck cancer	0.000429	0.0014	CcSEcCtD
Boceprevir—Constipation—Docetaxel—head and neck cancer	0.000426	0.00139	CcSEcCtD
Boceprevir—Pain—Docetaxel—head and neck cancer	0.000426	0.00139	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CDH1—head and neck cancer	0.000414	0.0016	CbGpPWpGaD
Boceprevir—Feeling abnormal—Docetaxel—head and neck cancer	0.00041	0.00134	CcSEcCtD
Boceprevir—Nausea—Fluorouracil—head and neck cancer	0.00041	0.00134	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000407	0.00133	CcSEcCtD
Boceprevir—Body temperature increased—Docetaxel—head and neck cancer	0.000394	0.00129	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—head and neck cancer	0.000394	0.00129	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000384	0.00149	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000379	0.00147	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2L1—head and neck cancer	0.000375	0.00145	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2L1—head and neck cancer	0.000375	0.00145	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—BCL2—head and neck cancer	0.000375	0.00145	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PTEN—head and neck cancer	0.000375	0.00145	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PTEN—head and neck cancer	0.000375	0.00145	CbGpPWpGaD
Boceprevir—Hypersensitivity—Docetaxel—head and neck cancer	0.000367	0.0012	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—PTEN—head and neck cancer	0.00036	0.00139	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PTEN—head and neck cancer	0.00036	0.00139	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CASP8—head and neck cancer	0.00036	0.00139	CbGpPWpGaD
Boceprevir—Asthenia—Docetaxel—head and neck cancer	0.000357	0.00117	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—head and neck cancer	0.000352	0.00115	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.00035	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CDH1—head and neck cancer	0.000341	0.00132	CbGpPWpGaD
Boceprevir—Diarrhoea—Docetaxel—head and neck cancer	0.000341	0.00111	CcSEcCtD
Boceprevir—Dizziness—Docetaxel—head and neck cancer	0.000329	0.00108	CcSEcCtD
Boceprevir—ABCB1—lymph node—head and neck cancer	0.000323	0.0011	CbGeAlD
Boceprevir—CTSV—Innate Immune System—MAPK3—head and neck cancer	0.00032	0.00124	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MAPK3—head and neck cancer	0.00032	0.00124	CbGpPWpGaD
Boceprevir—Vomiting—Docetaxel—head and neck cancer	0.000317	0.00103	CcSEcCtD
Boceprevir—Rash—Docetaxel—head and neck cancer	0.000314	0.00103	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—head and neck cancer	0.000314	0.00102	CcSEcCtD
Boceprevir—Headache—Docetaxel—head and neck cancer	0.000312	0.00102	CcSEcCtD
Boceprevir—CTSK—Immune System—BCL2L1—head and neck cancer	0.000311	0.0012	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PTEN—head and neck cancer	0.00031	0.0012	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—BCL2—head and neck cancer	0.000309	0.00119	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CASP8—head and neck cancer	0.000307	0.00119	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CASP8—head and neck cancer	0.000307	0.00119	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000306	0.00118	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MAPK1—head and neck cancer	0.000305	0.00118	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MAPK1—head and neck cancer	0.000305	0.00118	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—head and neck cancer	0.000305	0.00118	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—head and neck cancer	0.000305	0.00118	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CDH1—head and neck cancer	0.000303	0.00117	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDH1—head and neck cancer	0.000303	0.00117	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000302	0.00117	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000299	0.00116	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PTEN—head and neck cancer	0.000298	0.00115	CbGpPWpGaD
Boceprevir—Nausea—Docetaxel—head and neck cancer	0.000296	0.000966	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000295	0.00114	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—head and neck cancer	0.000292	0.00113	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—head and neck cancer	0.000292	0.00113	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000291	0.00113	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000284	0.0011	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000282	0.00109	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00028	0.00108	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000278	0.00107	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK3—head and neck cancer	0.000265	0.00103	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PIK3CA—head and neck cancer	0.000264	0.00102	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PIK3CA—head and neck cancer	0.000264	0.00102	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2—head and neck cancer	0.000263	0.00102	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2—head and neck cancer	0.000263	0.00102	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2L1—head and neck cancer	0.000256	0.000992	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PTEN—head and neck cancer	0.000256	0.00099	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CASP8—head and neck cancer	0.000254	0.000985	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—head and neck cancer	0.000254	0.000982	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—head and neck cancer	0.000254	0.000982	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK1—head and neck cancer	0.000252	0.000977	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—head and neck cancer	0.000252	0.000977	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDH1—head and neck cancer	0.000251	0.000973	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—UROD—head and neck cancer	0.000249	0.000965	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000248	0.000961	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PTEN—head and neck cancer	0.000245	0.00095	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—head and neck cancer	0.000245	0.000947	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—HRAS—head and neck cancer	0.000245	0.000947	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—head and neck cancer	0.000242	0.000938	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—head and neck cancer	0.000235	0.000909	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HRAS—head and neck cancer	0.000235	0.000909	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—head and neck cancer	0.000232	0.000898	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—head and neck cancer	0.000232	0.000898	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.00022	0.000851	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—head and neck cancer	0.000219	0.000848	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK3—head and neck cancer	0.000218	0.000846	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2—head and neck cancer	0.000218	0.000845	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—head and neck cancer	0.000218	0.000845	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—head and neck cancer	0.000218	0.000845	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—head and neck cancer	0.000216	0.000836	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—head and neck cancer	0.000216	0.000836	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000216	0.000835	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000211	0.000817	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—head and neck cancer	0.00021	0.000814	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00021	0.000813	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CASP8—head and neck cancer	0.000209	0.000811	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK1—head and neck cancer	0.000208	0.000805	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—head and neck cancer	0.000208	0.000804	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—head and neck cancer	0.000207	0.000803	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—head and neck cancer	0.000207	0.000803	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—head and neck cancer	0.000207	0.000801	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—HRAS—head and neck cancer	0.000203	0.000784	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOTCH1—head and neck cancer	0.000203	0.000784	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—head and neck cancer	0.0002	0.000772	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—head and neck cancer	0.000195	0.000755	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—head and neck cancer	0.000195	0.000755	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—head and neck cancer	0.000195	0.000753	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—head and neck cancer	0.000192	0.000744	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UROD—head and neck cancer	0.000188	0.000729	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.000187	0.000723	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK3—head and neck cancer	0.000186	0.000722	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK3—head and neck cancer	0.000186	0.000722	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTEN—head and neck cancer	0.000181	0.0007	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PIK3CA—head and neck cancer	0.00018	0.000698	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—head and neck cancer	0.00018	0.000696	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—head and neck cancer	0.000179	0.000693	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK1—head and neck cancer	0.000177	0.000687	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK1—head and neck cancer	0.000177	0.000687	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—head and neck cancer	0.000177	0.000687	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—head and neck cancer	0.000177	0.000687	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—head and neck cancer	0.000173	0.00067	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—head and neck cancer	0.000172	0.000665	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—head and neck cancer	0.000167	0.000646	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—head and neck cancer	0.000162	0.000626	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—head and neck cancer	0.00016	0.00062	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—head and neck cancer	0.000158	0.000613	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK3—head and neck cancer	0.000154	0.000598	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—head and neck cancer	0.000154	0.000596	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—head and neck cancer	0.000154	0.000596	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—head and neck cancer	0.000149	0.000576	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—head and neck cancer	0.000147	0.00057	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK1—head and neck cancer	0.000147	0.000569	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—head and neck cancer	0.000147	0.000569	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000144	0.000556	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—head and neck cancer	0.000142	0.000551	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—head and neck cancer	0.000142	0.000551	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—head and neck cancer	0.000141	0.000548	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—head and neck cancer	0.000139	0.00054	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000139	0.000538	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000138	0.000533	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000137	0.000531	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—head and neck cancer	0.000136	0.000526	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—head and neck cancer	0.000133	0.000515	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000132	0.00051	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—head and neck cancer	0.000131	0.000508	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00013	0.000503	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—head and neck cancer	0.000128	0.000494	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK3—head and neck cancer	0.000127	0.000492	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—head and neck cancer	0.000126	0.000487	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—head and neck cancer	0.000126	0.000487	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000123	0.000477	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK1—head and neck cancer	0.000121	0.000469	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—head and neck cancer	0.000121	0.000468	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—head and neck cancer	0.000118	0.000459	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—head and neck cancer	0.000118	0.000457	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—head and neck cancer	0.000117	0.000454	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000117	0.000453	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UROD—head and neck cancer	0.000116	0.000449	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK3—head and neck cancer	0.000112	0.000434	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK1—head and neck cancer	0.000107	0.000413	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—head and neck cancer	0.000107	0.000413	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000106	0.000409	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—head and neck cancer	0.000105	0.000407	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—head and neck cancer	0.000104	0.000403	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NAT2—head and neck cancer	0.000104	0.000401	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000102	0.000395	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—head and neck cancer	9.72e-05	0.000376	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—head and neck cancer	9.25e-05	0.000358	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	9.22e-05	0.000357	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DPYD—head and neck cancer	9.08e-05	0.000352	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—head and neck cancer	8.95e-05	0.000346	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	8.72e-05	0.000337	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—YAP1—head and neck cancer	8.62e-05	0.000334	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—head and neck cancer	8.58e-05	0.000332	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—head and neck cancer	8.56e-05	0.000331	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	8.3e-05	0.000321	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	8.29e-05	0.000321	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NAT2—head and neck cancer	7.81e-05	0.000303	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—head and neck cancer	7.56e-05	0.000293	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	7.2e-05	0.000279	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.96e-05	0.00027	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DPYD—head and neck cancer	6.85e-05	0.000265	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—YAP1—head and neck cancer	6.5e-05	0.000252	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.88e-05	0.000228	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—head and neck cancer	5.17e-05	0.0002	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—head and neck cancer	5.11e-05	0.000198	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—head and neck cancer	4.9e-05	0.00019	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A1—head and neck cancer	4.85e-05	0.000188	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAT2—head and neck cancer	4.81e-05	0.000186	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DPYD—head and neck cancer	4.22e-05	0.000163	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—YAP1—head and neck cancer	4.01e-05	0.000155	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—head and neck cancer	3.9e-05	0.000151	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—head and neck cancer	3.86e-05	0.000149	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—head and neck cancer	3.7e-05	0.000143	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.66e-05	0.000142	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.88e-05	0.000112	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—head and neck cancer	2.51e-05	9.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—head and neck cancer	2.41e-05	9.31e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.38e-05	9.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—head and neck cancer	2.28e-05	8.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.25e-05	8.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—head and neck cancer	2.18e-05	8.42e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—head and neck cancer	1.9e-05	7.35e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.77e-05	6.87e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—head and neck cancer	1.45e-05	5.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.34e-05	5.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.34e-05	5.18e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—head and neck cancer	1.17e-05	4.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—head and neck cancer	1.09e-05	4.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.25e-06	3.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—head and neck cancer	6.74e-06	2.61e-05	CbGpPWpGaD
